Law360, New York (February 25, 2013, 12:50 PM EST) -- Electronic barcoding is an initiative launched by the Chinese State Food and Drug Administration (SFDA) in 2006 with an objective to better supervise the entire supply chain of pharmaceutical products. It was initially applied to domestically produced narcotics and psychotropic drugs as part of the legislative mandate arising from the administrative measures for narcotics and psychotropic drugs and subsequently applied to some domestically produced high-risk pharmaceutical products, including blood products, vaccines, injectables made by traditional chinese medicines (TCM) and compound preparations containing ephedrine, codeine and diphenoxylate. All essential drugs have been subject to electronic barcoding by February 2012....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
